Full-Time

Training Professional

Posted on 11/23/2025

Sartorius

Sartorius

5,001-10,000 employees

Laboratory instruments and bioprocess solutions

No salary listed

Bengaluru, Karnataka, India

In Person

Category
Training
Requirements
  • Degree in Instrumentation/Electrical/Automation Engineering combined with several years of professional experience.
  • Able to handle multi-tasks and possess problem-solving skills.
  • Self-driven, good team player with good work attitude and proactive.
  • Extensive experience in training & coaching.
  • First experience in a Technical Support, Inhouse- or Field Service Technician role is an advantage
  • Basic understanding of GMP, processes and applications in Life Sciences and / or Biotechnology and the willingness to further develop technical skills.
  • Strong digital expertise, and high affinity for new media and tools.
  • Excellent communication skills in English.
  • High customer orientation, strong communication and presentation skills, intercultural competencies.
  • Willingness to travel occasionally as needed.
Responsibilities
  • Create training concepts and arranged trainings in several formats, (like e.g. classroom, online, e-learning, remote) on the fundamentals of our bioprocess instruments.
  • Coordinate and perform trainings for our APAC Service team.
  • Implement trainings especially for acquired products and solutions.
  • Work on CAQ Tool to accomplished Training Goals and create training templates.
  • Follow-up and evaluate training results.
  • Be accountable for administration of trainings, training documentation and training equipment’s.
  • Represent APAC in Competency Management Program.
  • Drive continuous improvement activities for training quality and performance
  • Collaborate with internal experts and external vendors to deliver training courses for internal employees
  • Forecast required training courses needed by APAC Field Service and ensure adequate resources to meet training requests.
  • Maintain Technical Competency Matrix of all Field Service Engineers from APAC
  • Maintain Service Training center, Bangalore and utilized facility to train Field Service Team
  • Deliver Soft Skill training as well as trainer courses to participants
  • Collaborate with internal experts and external vendors to deliver training courses for internal employees
  • Record training feedback and create
  • Closely collaborate with the Manager of Technical Training in EMEA, NA and on global level
  • Provide weekly reports on the status of Technical Trainings demand -supply-feedback
  • Support arranging Invitation letters as well as travel arrangement for overseas participants
  • Maintain Training Equipment’s and tools installed in training center, Bangalore
Desired Qualifications
  • Identification with our core values: Sustainability, Openness, Enjoyment.
  • What will convince us: Degree in Instrumentation/Electrical/Automation Engineering combined with several years of professional experience.
  • What will convince us: Able to handle multi-tasks and possess problem-solving skills.
  • What will convince us: Self-driven, good team player with good work attitude and proactive.
  • What will convince us: Extensive experience in training & coaching.
  • What will convince us: First experience in a Technical Support, Inhouse- or Field Service Technician role is an advantage
  • What will convince us: Basic understanding of GMP, processes and applications in Life Sciences and / or Biotechnology and the willingness to further develop technical skills.
  • What will convince us: Strong digital expertise, and high affinity for new media and tools.
  • What will convince us: Excellent communication skills in English.
  • What will convince us: High customer orientation, strong communication and presentation skills, intercultural competencies.
  • What will convince us: Willingness to travel occasionally as needed.

Sartorius is a global partner in life sciences research and biopharmaceutical manufacturing. It provides laboratories with innovative instruments and consumables for research and quality control, and it offers Bioprocess Solutions focused on single-use systems that help manufacture biotech medicines, vaccines, and cell- and gene- therapies safely, quickly, and cost-effectively. Its products support the full path from drug discovery to commercial manufacturing, with a large worldwide footprint of more than 60 sites and a mission to help more people access better medicines. Sartorius differentiates itself through its broad portfolio spanning lab and bioprocess needs, a strong emphasis on single-use technologies, continuous portfolio expansion via acquisitions, and deep expertise serving pharmaceutical, biotech, and academic customers. Its goal is to simplify progress from research and development to scalable manufacturing so that life-saving medicines can reach patients worldwide.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Göttingen, Germany

Founded

1870

Simplify Jobs

Simplify's Take

What believers are saying

  • Goldman Sachs upgrades Sartorius Stedim Biotech to Buy rating.
  • Sartorius achieves 3.5 billion euros sales revenue in 2025.
  • Management forecasts 5-9% sales growth for 2026 with MATTEK contributions.

What critics are saying

  • Thermo Fisher undercuts Sartorius bioreactors, capturing 15-20% market share.
  • Danaher's Cytiva launches Sartocon competitor with 30% higher throughput.
  • Chinese clones replicate Arium Mini at 40% lower cost, eroding Asia sales.

What makes Sartorius unique

  • Sartorius launches Arium Mini Extend for versatile Type 1 water dispensing.
  • Sartorius opens $100M Bioanalytics CoE in Ann Arbor, Michigan.
  • Sartorius partners with Sanofi on downstream process intensification.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Flexible Work Hours

Wellness Program

Professional Development Budget

Company News

The Associated Press
Mar 16th, 2026
Sartorius launches platform to cut CAR-T manufacturing costs by 90% and quadruple output

Sartorius has launched the Eveo Cell Therapy Platform, an integrated system for producing autologous cell therapies including CAR-T treatments. The modular platform can increase output up to fourfold in existing cleanroom space whilst reducing manufacturing costs by approximately 90 percent. The system integrates cell selection, activation, gene modification, expansion and final formulation into a closed system. Its compact design allows a single operator to process eight patient batches simultaneously in the space traditionally needed for two, potentially producing over 350 doses annually compared to today's 100 doses in the same footprint. A successful pilot with CDMO ElevateBio validated the platform's real-world applicability. Sartorius will begin taking orders in September 2026, with first deliveries expected in 2027.

Yahoo Finance
Feb 3rd, 2026
Sartorius grows revenue 7.6% to €3.5B with EBITDA margin expanding to 29.7%

Sartorius AG reported strong Q4 2025 results, with revenue growing 7.6% in constant currencies to over €3.5 billion, exceeding full-year guidance. The company's EBITDA margin expanded 170 basis points to 29.7%, whilst underlying net profit increased 18%. The bioprocess solutions division drove growth with 9.5% revenue increase in constant currency, supported by strong double-digit growth in recurring revenue. However, the lab products and services division remained essentially flat at 0.2% growth, facing challenges from unfavorable product mix. Sartorius improved its net debt to EBITDA ratio from 3.96 times to 3.55 times, demonstrating financial discipline. The company set a broad guidance range for 2026, citing macroeconomic volatility. Management noted that US onshoring initiatives are expected to impact revenue from 2027 onwards rather than 2026.

Yahoo Finance
Feb 3rd, 2026
Sartorius Stedim Biotech posts 18% profit growth despite equipment softness, cuts debt ratio to 3.55

Sartorius Stedim Biotech reported strong profit growth for Q4 2025, with revenue increasing 7.6% in constant currencies to over €3.5 billion. The EBITDA margin improved 170 basis points to 29.7%, whilst underlying net profit surged 18%. The bioprocess solutions division led growth at 9.5% in constant currency, driven by double-digit growth in recurring revenue that offset continued equipment softness. Order intake grew faster than sales, with the book-to-bill ratio remaining above one. Free cash flow reached €390 million, though operating cash flow declined to €837 million from €976 million previously. The net debt-to-EBITDA ratio improved from 3.96 to 3.55 times. However, the company faces headwinds from a weaker US dollar and set broad 2026 guidance due to market volatility.

Firmenpresse
Sep 16th, 2025
Repairon secures funding for heart therapy

Repairon GmbH, a German biotech company, has secured a substantial Series A funding for its innovative "heart patch" therapy aimed at treating advanced heart failure. The funding, led by Bioventure Management GmbH and co-invested by Satorius AG, will support the Phase 3 trial and GMP production scaling. The heart patch, made from engineered heart muscle, is applied to damaged heart tissue to restore function. Positive preclinical and Phase 1/2 results were published in Nature.

IT Juzi
Aug 12th, 2025
Nanotein secures $3M strategic investment

Nanotein, a cell therapy developer, has secured a $3 million strategic investment from Sartorius Stedim Biotech.

INACTIVE